Stiff FDA regulation imposes high costs on development of new and innovative drugs in the United States. But stiff competition in America’s free markets still enables America to lead the world in development of new, cutting edge, breakthrough drugs, leading the world in treatment and care especially for America’s seniors, most in need of the world’s best health care. Foreign countries often free ride on America’s free market system, gaining access to the drug breakthroughs after American patents run out, without allowing the freedom for the innovators to recoup the cost of their heavily regulated innovation. That is one reason...